Rafferty Asset Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-223,080
| Closed | -$1.49M | – | 1104 |
|
|
2023
Q3 | $1.49M | Buy |
223,080
+27,436
| +14% | +$183K | 0.01% | 699 |
|
|
2023
Q2 | $1.77M | Buy |
195,644
+24,909
| +15% | +$226K | 0.01% | 682 |
|
|
2023
Q1 | $1.24M | Sell |
170,735
-126,643
| -43% | -$921K | 0.01% | 745 |
|
|
2022
Q4 | $2.17M | Buy |
297,378
+148,802
| +100% | +$1.08M | 0.02% | 548 |
|
|
2022
Q3 | $1.15M | Buy |
148,576
+90,366
| +155% | +$698K | 0.01% | 633 |
|
|
2022
Q2 | $396K | Buy |
+58,210
| New | +$396K | ﹤0.01% | 839 |
|